Events Partner Content Advancing the Next Generation of Microbiome-Based Therapeuti... Join the Microbiome Movement in Asia
Partner Content Partner Content 4 Reasons Why Asia is the Next Hub of Microbiome Innovation Microbiome R&D in Asia-Pacific
News Promethera looks to Asia with €10m investment Belgium-based liver disease specialists Promethera Biosciences have received a leg-up for the Asian market in the form of a €10 million investment from Japanese business conglomerate ITOCHU Corp
Oncology LSX2026: Addressing adult eye cancer, with Roi Raz Roi Raz, CEO of ReBio Pharma, discusses injectable, bioresorbable sustained release delivery for ophthalmic therapeutics at LSX 2026.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
